Literature DB >> 19923572

Recrudescent Campylobacter jejuni infection in an immunocompetent adult following experimental infection with a well-characterized organism.

Shahida Baqar1, David R Tribble, Marya Carmolli, Katrin Sadigh, Frederic Poly, Chad Porter, Catherine J Larsson, Kristen K Pierce, Patricia Guerry, Michael Darsley, Beth Kirkpatrick.   

Abstract

The recrudescence of infection with Campylobacter jejuni after appropriate antibiotic treatment has not been previously reported in an immunocompetent adult. We present the complete clinical, microbiologic, and immunologic evaluation of a closely monitored healthy male with recrudescent C. jejuni infection occurring in the absence of immunodeficiency following experimental infection with a well-characterized strain. After antibiotic treatment, the initial infection was clinically cleared and microbiologically undetectable. Subsequently, two episodes of recrudescence occurred, with no change in in vitro antibiotic sensitivity being detected. The immune responses of the individual were compared to those of other participants in the experimental infection study: innate immune responses, including fecal cytokines and C-reactive protein, were intact; however, measures of Campylobacter-specific adaptive immune responses were absent, including serum antibodies, antibody-secreting cells, and in vitro gamma interferon responses. No primary or secondary immunodeficiency was identified. Recrudescent Campylobacter infections after treatment may be more common than has previously been appreciated. This work adds to our understanding of the human immune response to natural Campylobacter infection and reiterates the importance of pathogen-specific adaptive immune responses to this globally important pathogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19923572      PMCID: PMC2812103          DOI: 10.1128/CVI.00252-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  46 in total

1.  Practice guidelines for the management of infectious diarrhea.

Authors:  R L Guerrant; T Van Gilder; T S Steiner; N M Thielman; L Slutsker; R V Tauxe; T Hennessy; P M Griffin; H DuPont; R B Sack; P Tarr; M Neill; I Nachamkin; L B Reller; M T Osterholm; M L Bennish; L K Pickering
Journal:  Clin Infect Dis       Date:  2001-01-30       Impact factor: 9.079

Review 2.  Special feature for the Olympics: effects of exercise on the immune system: exercise effects on mucosal immunity.

Authors:  M Gleeson; D B Pyne
Journal:  Immunol Cell Biol       Date:  2000-10       Impact factor: 5.126

3.  Special feature for the Olympics: effects of exercise on the immune system. Overview: exercise immunology.

Authors:  M Gleeson
Journal:  Immunol Cell Biol       Date:  2000-10       Impact factor: 5.126

4.  Pre-exposure anti-Campylobacter jejuni immunoglobulin a levels associated with reduced risk of Campylobacter diarrhea in adults traveling to Thailand.

Authors:  S E Walz; S Baqar; H J Beecham; P Echeverria; C Lebron; M McCarthy; R Kuschner; S Bowling; A L Bourgeois; D A Scott
Journal:  Am J Trop Med Hyg       Date:  2001-11       Impact factor: 2.345

5.  Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow-up study of 210 patients.

Authors:  M A Strid; J Engberg; L B Larsen; K Begtrup; K Mølbak; K A Krogfelt
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

6.  Immunogens of interest for the diagnosis of Campylobacter jejuni infections.

Authors:  B Janvier; S Ayraud; A Beby-Defaux; J Louis Fauchère
Journal:  FEMS Immunol Med Microbiol       Date:  2000-03

7.  Relationship of Campylobacter toxigenicity in vitro to the development of postinfectious irritable bowel syndrome.

Authors:  J P Thornley; D Jenkins; K Neal; T Wright; J Brough; R C Spiller
Journal:  J Infect Dis       Date:  2001-07-26       Impact factor: 5.226

8.  Campylobacter jejuni enteritis.

Authors:  S Baqar; B Rice; L Lee; A L Bourgeois; A N El Din; D R Tribble; G P Heresi; A S Mourad; J R Murphy
Journal:  Clin Infect Dis       Date:  2001-08-21       Impact factor: 9.079

Review 9.  Association between Campylobacter infection and Guillain-Barré syndrome.

Authors:  B M Allos
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

10.  Campylobacter-triggered reactive arthritis: a population-based study.

Authors:  T Hannu; L Mattila; H Rautelin; P Pelkonen; P Lahdenne; A Siitonen; M Leirisalo-Repo
Journal:  Rheumatology (Oxford)       Date:  2002-03       Impact factor: 7.580

View more
  13 in total

1.  Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis.

Authors:  Juan Aguilar-Company; Ibai Los-Arcos; Carles Pigrau; Dolors Rodríguez-Pardo; María Nieves Larrosa; Virginia Rodríguez-Garrido; Denisse Sihuay-Diburga; Benito Almirante
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 2.  Global Epidemiology of Campylobacter Infection.

Authors:  Nadeem O Kaakoush; Natalia Castaño-Rodríguez; Hazel M Mitchell; Si Ming Man
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

3.  Enteric campylobacteria and RNA viruses associated with healthy and diarrheic humans in the Chinook health region of southwestern Alberta, Canada.

Authors:  G Douglas Inglis; Valerie F Boras; Alain Houde
Journal:  J Clin Microbiol       Date:  2010-11-24       Impact factor: 5.948

4.  Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infection.

Authors:  J C Lindow; F Poly; D R Tribble; P Guerry; M P Carmolli; S Baqar; C K Porter; K K Pierce; M J Darsley; K S Sadigh; E A Dill; B D Kirkpatrick
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

5.  The polysaccharide capsule of Campylobacter jejuni modulates the host immune response.

Authors:  Alexander C Maue; Krystle L Mohawk; David K Giles; Frédéric Poly; Cheryl P Ewing; Yuening Jiao; Ginyoung Lee; Zuchao Ma; Mario A Monteiro; Christina L Hill; Jason S Ferderber; Chad K Porter; M Stephen Trent; Patricia Guerry
Journal:  Infect Immun       Date:  2012-12-17       Impact factor: 3.441

6.  Lack of homologous protection against Campylobacter jejuni CG8421 in a human challenge model.

Authors:  Beth D Kirkpatrick; Caroline E Lyon; Chad K Porter; Alex C Maue; Patricia Guerry; Kristen K Pierce; Marya P Carmolli; Mark S Riddle; Catherine J Larsson; Douglas Hawk; Elizabeth A Dill; A Fingar; Frederic Poly; Kelly A Fimlaid; Fahmida Hoq; David R Tribble
Journal:  Clin Infect Dis       Date:  2013-07-09       Impact factor: 9.079

7.  Peripheral CD4+ T cell cytokine responses following human challenge and re-challenge with Campylobacter jejuni.

Authors:  Kelly A Fimlaid; Janet C Lindow; David R Tribble; Janice Y Bunn; Alexander C Maue; Beth D Kirkpatrick
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

8.  Microevolution of Campylobacter jejuni during long-term infection in an immunocompromised host.

Authors:  Clare R Barker; Anaïs Painset; Craig Swift; Claire Jenkins; Gauri Godbole; Martin C J Maiden; Timothy J Dallman
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

Review 9.  Polyphosphate and associated enzymes as global regulators of stress response and virulence in Campylobacter jejuni.

Authors:  Anand Kumar; Dharanesh Gangaiah; Jordi B Torrelles; Gireesh Rajashekara
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

10.  Campylobacter jejuni transcriptional and genetic adaptation during human infection.

Authors:  Alexander A Crofts; Frédéric M Poly; Cheryl P Ewing; Janelle M Kuroiwa; Joanna E Rimmer; Clayton Harro; David Sack; Kawsar R Talaat; Chad K Porter; Ramiro L Gutierrez; Barbara DeNearing; Jessica Brubaker; Renée M Laird; Alexander C Maue; Kayla Jaep; Ashley Alcala; David R Tribble; Mark S Riddle; Amritha Ramakrishnan; Andrea J McCoy; Bryan W Davies; Patricia Guerry; M Stephen Trent
Journal:  Nat Microbiol       Date:  2018-03-27       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.